These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 17530506

  • 21. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 22. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.
    Arch Intern Med; 2009 Aug 10; 169(15):1403-10. PubMed ID: 19667304
    [Abstract] [Full Text] [Related]

  • 23. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE, Hagiwara M, Stanford RH, Stempel DA.
    Clin Ther; 2008 Mar 10; 30(3):560-71. PubMed ID: 18405796
    [Abstract] [Full Text] [Related]

  • 24. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
    Akazawa M, Biddle AK, Stearns SC.
    Clin Ther; 2008 Mar 10; 30 Spec No():1003-16. PubMed ID: 18640475
    [Abstract] [Full Text] [Related]

  • 25. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
    Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, TORCH investigators.
    N Engl J Med; 2007 Feb 22; 356(8):775-89. PubMed ID: 17314337
    [Abstract] [Full Text] [Related]

  • 26. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
    Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G.
    Clin Ther; 2009 May 22; 31(5):1056-63. PubMed ID: 19539106
    [Abstract] [Full Text] [Related]

  • 27. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS, Yawn BP.
    Curr Med Res Opin; 2007 Feb 22; 23(2):427-34. PubMed ID: 17288696
    [Abstract] [Full Text] [Related]

  • 28. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
    Schermer TR, Albers JM, Verblackt HW, Costongs RJ, Westers P.
    Fam Pract; 2007 Apr 22; 24(2):181-8. PubMed ID: 17251178
    [Abstract] [Full Text] [Related]

  • 29. [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].
    Fang LZ, Liang X, Zhang JQ, Liu L, Fu WP, Zhao ZH, Dai LM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov 22; 31(11):811-4. PubMed ID: 19080533
    [Abstract] [Full Text] [Related]

  • 30. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.
    Vestbo J, Pauwels R, Anderson JA, Jones P, Calverley P, TRISTSAN study group.
    Thorax; 2005 Apr 22; 60(4):301-4. PubMed ID: 15790985
    [Abstract] [Full Text] [Related]

  • 31. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM.
    Curr Med Res Opin; 2009 Sep 22; 25(9):2251-8. PubMed ID: 19622006
    [Abstract] [Full Text] [Related]

  • 32. Adherence to asthma controller medication regimens.
    Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP.
    Respir Med; 2005 Oct 22; 99(10):1263-7. PubMed ID: 16140227
    [Abstract] [Full Text] [Related]

  • 33. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
    Corda L, Bertella E, La Piana GE, Boni E, Redolfi S, Tantucci C.
    Respiration; 2008 Oct 22; 76(1):61-8. PubMed ID: 18319586
    [Abstract] [Full Text] [Related]

  • 34. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A, Gessner C, Hoheisel G, Juergens U.
    Pneumologie; 2008 Jul 22; 62(7):430-7. PubMed ID: 18398787
    [Abstract] [Full Text] [Related]

  • 35. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma.
    Masoli M, Weatherall M, Holt S, Beasley R.
    Thorax; 2005 Sep 22; 60(9):730-4. PubMed ID: 16135679
    [Abstract] [Full Text] [Related]

  • 36. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug 22; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 37. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L.
    Am J Geriatr Pharmacother; 2008 Aug 22; 6(3):138-46. PubMed ID: 18775388
    [Abstract] [Full Text] [Related]

  • 38. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
    Stempel DA, Riedel AA, Carranza Rosenzweig JR.
    Curr Med Res Opin; 2006 Mar 22; 22(3):463-70. PubMed ID: 16574030
    [Abstract] [Full Text] [Related]

  • 39. Clinical and pharmacoeconomic profile of COPD patients with FEV1 50--60% predicted: pilot study on the impact of the extended indication of ICS/LABA.
    Dal Negro RW, Bonadiman L, Turati C, Turco P.
    Ther Adv Respir Dis; 2009 Apr 22; 3(2):51-8. PubMed ID: 19443518
    [Abstract] [Full Text] [Related]

  • 40. [Salmeterol + fluticasone in COPD. Complementary treatment principles hold true in the COPD management, too].
    MMW Fortschr Med; 2003 Nov 13; 145(46):47. PubMed ID: 14699834
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.